GlassScriptPhysician profile
Nancy William Bethuel
NPI 1154816734
$1,392.55
in general payments reported to CMS, 2019-2025
19 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $668 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $668 · Food and Beverage: $546 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $667.51 |
| Food and Beverage | $546.06 |
| Education | $178.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $667.51 | 2023 | Da Vinci Surgical System |
| Mallinckrodt Hospital Products INC. | $116.48 | 2025 | Acthar |
| Genzyme Corporation | $84.77 | 2025 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Glaxosmithkline, LLC. | $62.47 | 2025 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $55.28 | 2025 | Glassia |
| Cumberland Pharmaceuticals, INC. | $46.92 | 2025 | Vibativ |
| Merck Sharp & Dohme LLC | $45.14 | 2025 | Pifeltro |
| Astrazeneca Pharmaceuticals LP | $41.47 | 2025 | Fasenra |
| Pfizer INC. | $27.39 | 2025 | |
| Aimmune Therapeutics, INC. | $20.16 | 2025 | Vowst |
| Electromed, INC. | $20.03 | 2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $20.00 | 2025 | |
| Baxter Healthcare | $19.87 | 2025 | Hillrom - Monarch Airway Clearance System |
| Grifols USA, LLC | $19.70 | 2025 | Prolastin-C Liquid |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.94 | 2025 | Tezspire |
| Philips North America LLC | $17.92 | 2025 | Vest Therapy Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.91 | 2025 | Jascayd |
| Inspire Medical Systems, INC. | $14.60 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Bethuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.